| Prevention and management of febrile neutropenia in acute myeloid leukaemia and higher risk myelodysplastic syndrome : An international survey of current practice | British journal of haematology |  | | 2026 | 10 | 120 |
|
| Single-kidney transplantation with discarded partner kidney vs. Dual kidney transplantation : results from a national cohort study | BMC nephrology | | | 2026 | 15 | 19 |
|
| Preformed donor-specific antibodies are associated with acute rejection and biliary complications after liver transplantation : A Swiss Transplant Cohort Study analysis | Liver transplantation | | | 2026 | 19 | 74 |
|
| Does early letermovir initiation delay engraftment ? | Antimicrobial agents and chemotherapy | | | 2026 | 8 | 64 |
|
| Prospective evaluation of imipenem trough concentrations and clinical outcomes in critically ill patients | Journal of antimicrobial chemotherapy | | | 2026 | 10 | 22 |
|
| Pretransplant CMV-IgG Titers and DNAemia Are Associated With CMV Infections Post Allogeneic Hematopoietic Cell Transplant With or Without Letermovir | Open forum infectious diseases | | | 2026 | 10 | 49 |
|
| Incidence and Risk Factors for Infection in Heart Transplant Recipients on Posttransplant Extracorporeal Membrane Oxygenation (ECMO) | Transplantation direct | | | 2025 | 24 | 106 |
|
| Comparing variable and feature selection strategies for prediction - protocol of a simulation study in low-dimensional transplantation data | PloS one | | | 2025 | 26 | 215 |
|
| Old Pathogens-New Patient Types : Infections in a CAR T-Cell Recipient. Could It Get Any More Complicated ? | Transplant infectious disease | | | 2025 | 15 | 59 |
|
| The Importance of MRI in the Early Diagnosis of Acute Invasive Fungal Rhinosinusitis | Diagnostics | | | 2025 | 162 | 234 |
|
| Defining bloodstream and central venous catheter-related infections in patients following haematopoietic cell transplantation : position paper of the European Blood and Marrow Transplantation Society Infectious Diseases Working Party and Practice Harmonization and Guidelines Committee | Clinical microbiology and infection |  | | 2025 | 12 | 0 |
|
| Blood virome after allogeneic hematopoietic stem cell transplantation | Open forum infectious diseases | | | 2025 | 72 | 158 |
|
| Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation : recommendations from the 10th European Conference on Infections in Leukaemia | The Lancet Infectious Diseases | | | 2025 | 24 | 0 |
|
| Enhancing post-kidney transplant prognostication: an interpretable machine learning approach for longitudinal outcome prediction | npj digital medicine | | | 2025 | 11 | 24 |
|
| Isolation measures during the COVID-19 pandemic in transplant units may decrease respiratory infection rates and improve non-relapse mortality | Bone marrow transplantation | | | 2025 | 14 | 0 |
|
| Pneumonia definition in allogeneic hematopoietic cell transplant recipients : Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee | Current research in translational medicine | | | 2025 | 18 | 45 |
|
| Invasive Candida infections in solid organ transplant recipients between 2008 and 2020 | American Journal of Transplantation | | | 2025 | 32 | 193 |
|
| Breakthrough Invasive Mould Infections Under Posaconazole Prophylaxis in Patients With Haematologic Malignancies : A Case-Control Study | Mycoses | | | 2025 | 16 | 115 |
|
| Management of Clostridioides difficile infection in patients with haematological malignancies and after cellular therapy : guidelines from 10th European Conference on Infections in Leukaemia (ECIL - 10) | EClinicalMedicine | | | 2025 | 13 | 197 |
|
| Population pharmacokinetic analysis of letermovir in adult hematopoietic cell transplant recipients | Antimicrobial agents and chemotherapy | | | 2025 | 19 | 60 |
|
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | | | 2025 | 81 | 246 |
|
| Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe : A systematic review by the European Conference on Infections in Leukemia (ECIL) | The Journal of infection | | | 2025 | 14 | 78 |
|
| Management of Invasive Pulmonary Aspergillosis in Intensive Care Units : Guidelines From the Fungal Infection Network of Switzerland (FUNGINOS) | Mycoses | | | 2025 | 21 | 716 |
|
| Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva, Switzerland | Infection | | | 2025 | 45 | 250 |
|
| Antifungal treatment duration in hematology patients with invasive mold infections : a real-life update | Open forum infectious diseases | | | 2024 | 98 | 140 |
|
| Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients : An Update | Viruses | | | 2024 | 15 | 204 |
|
| Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015–2019) | Infectious diseases and therapy | | | 2024 | 16 | 333 |
|
| Reexploring cytomegalovirus serology in allogeneic hematopoietic cell transplantation | Current opinion in infectious diseases | | | 2024 | 116 | 155 |
|
| Isavuconazole for the Treatment of Fungal Infections : A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS) | Open forum infectious diseases | | | 2024 | 91 | 255 |
|
| An Update on Breakthrough Invasive Mold Infections | Mycopathologia | | | 2024 | 14 | 106 |
|
| Current practice of screening and antimicrobial prophylaxis to prevent Gram-negative bacterial infection in high-risk haematology patients : results from a pan-European survey | Therapeutic advances in infectious disease | | | 2024 | 13 | 135 |
|
| Clinicopathologic conference : Bloodstream infection in an allogeneic hamatopoietic cell transplant : Thinking beyond the usual | Transplant infectious disease | | | 2024 | 43 | 99 |
|
| Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ? | Open forum infectious diseases | | | 2024 | 121 | 157 |
|
| Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients | Transplant international | | | 2024 | 119 | 234 |
|
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | | | 2024 | 58 | 117 |
|
| Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients : A multicenter cohort, 2015-2020 | American journal of transplantation | | | 2024 | 38 | 65 |
|
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | | | 2024 | 70 | 285 |
|
| Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species | Frontiers in medicine | | | 2024 | 96 | 97 |
|
| Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis | Transplant infectious disease | | | 2024 | 73 | 201 |
|
| Cefepime trough levels and clinical outcomes in patients undergoing universal therapeutic drug monitoring : A prospective cohort study | CMI communications | | | 2024 | 9 | 31 |
|
| Bacterial infections in solid organ transplant recipients | Current opinion in organ transplantation | | | 2024 | 41 | 1 |
|
| Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter study | Bone marrow transplantation | | | 2024 | 91 | 135 |
|
| How I treat : Coronavirus disease 2019 in leukemic patients and hematopoietic cell transplant recipients | Transplant infectious disease | | | 2024 | 16 | 327 |
|
| Pitfalls in definitions on respiratory viruses and particularities of Adenovirus infection in hematopoietic cell transplantation patients : Recommendations from the EBMT practice harmonization and guidelines committee | Current research in translational medicine | | | 2024 | 62 | 216 |
|
| Invasive aspergillosis in liver transplant recipients in the current era | American journal of transplantation | | | 2024 | 29 | 0 |
|
| Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplant | Open forum infectious diseases | | | 2023 | 97 | 157 |
|
| Comparing the Real-World Use of Isavuconazole to Other Anti-Fungal Therapy for Invasive Fungal Infections in Patients with and without Underlying Disparities : A Multi-Center Retrospective Study | Journal of Fungi | | | 2023 | 101 | 238 |
|
| 'Which trial do we need ? Culture of preservation fluid in abdominal organ transplant recipients' Author's reply | Clinical microbiology and infection | | | 2023 | 14 | 185 |
|
| Vaccine-preventable infections among solid organ transplant recipients in Switzerland | JAMA network open | | | 2023 | 147 | 198 |
|
| Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipients | Clinical infectious diseases | | | 2023 | 110 | 247 |
|
| Antifungal prophylaxis and pre-emptive therapy : when and how ? | Molecular aspects of medicine | | | 2023 | 91 | 74 |
|
| Which trial do we need ? Culture of preservation fluid in abdominal organ transplant recipients | Clinical microbiology and infection | | | 2023 | 14 | 61 |
|
| Duration of antifungal treatment in mold infection : when is enough ? | Current opinion in infectious diseases | | | 2023 | 102 | 186 |
|
| The present and future of blood virome in allogeneic hematopoietic cell transplant recipients | Current opinion in infectious diseases | | | 2023 | 104 | 234 |
|
| Bloodstream infections in allogeneic haematopoietic cell recipients from the swiss transplant cohort study: trends of causative pathogens and resistance rates | Bone marrow transplantation | | | 2023 | 159 | 136 |
|
| American Society for Transplantation and Cellular Therapy Series, #6 : Management of Invasive Candidiasis in Hematopoietic Cell Transplantation Recipients | Transplantation and cellular therapy | | | 2023 | 88 | 359 |
|
| CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients | Open forum infectious diseases | | | 2023 | 147 | 185 |
|
| Immunogenicity of High-Dose vs. MF59-adjuvanted vs. Standard Influenza Vaccine in Solid Organ Transplant Recipients : The STOP-FLU trial | Clinical infectious diseases | | | 2023 | 114 | 246 |
|
| Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial | Clinical infectious diseases | | | 2023 | 156 | 333 |
|
| Invasive Aspergillosis and the Impact of Azole-resistance | Current fungal infection reports | | | 2023 | 79 | 282 |
|
| Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma | Viruses | | | 2023 | 164 | 204 |
|
| Bacteremia During the First Year After Solid Organ Transplantation : An Epidemiological Update | Open forum infectious diseases | | | 2023 | 134 | 146 |
|
| Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients | Antimicrobial agents and chemotherapy | | | 2023 | 114 | 593 |
|
| Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant | Open forum infectious diseases | | | 2023 | 76 | 155 |
|
| Nouveautés dans la prise en charge de l’infection à cytomégalovirus chez les patients transplantés | Revue médicale suisse | | | 2023 | 104 | 150 |
|
| Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress? | Open forum infectious diseases | | | 2022 | 280 | 292 |
|
| Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study | The Journal of infection | | | 2022 | 267 | 401 |
|
| Friends and foes : “The quarrels of friends are the opportunities of foes” | Current opinion in infectious diseases | | | 2022 | 15 | 0 |
|
| Atypical pulmonary phaeohyphomycosis due to Aureobasidium spp. - case report and brief literature review | Swiss medical weekly | | | 2022 | 195 | 108 |
|
| Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals | Open forum infectious diseases | | | 2022 | 243 | 223 |
|
| Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients | Antimicrobial agents and chemotherapy | | | 2022 | 113 | 398 |
|
| A first update on mapping the human genetic architecture of COVID-19 | Nature | | | 2022 | 7 | 9 |
|
| Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections | Mycoses | | | 2022 | 312 | 224 |
|
| Impact of different urinary tract infection phenotypes within the first year post-transplant on renal allograft outcomes | American journal of transplantation | | | 2022 | 198 | 190 |
|
| Letermovir for cytomegalovirus primary prophylaxis in a multiple abdominal/small bowel transplant recipient | Clinical transplantation | | | 2022 | 265 | 0 |
|
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | | | 2022 | 252 | 156 |
|
| T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | | | 2022 | 270 | 159 |
|
| When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients? | Mycoses | | | 2022 | 109 | 114 |
|
| Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study | The Journal of hospital infection | | | 2022 | 263 | 176 |
|
| Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients | American journal of transplantation | | | 2022 | 222 | 174 |
|
| Screening for Parasitic Infection and Tuberculosis in Immunosuppressed and Pre-Immunosuppressed Patients: An Observational Study | Tropical medicine and infectious disease | | | 2021 | 252 | 296 |
|
| COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? | Clinical microbiology and infection | | | 2021 | 246 | 183 |
|
| Progress and current challenges in the management of invasive fungal infections in hematologic malignancy patients and allogeneic hematopoietic cell transplant recipients | | | | 2021 | 350 | 572 |
|
| Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study | Vaccines | | | 2021 | 213 | 340 |
|
| Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study | American journal of transplantation | | | 2021 | 287 | 234 |
|
| Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high-risk hematopoietic cell transplant recipients | Immunity, inflammation and disease | | | 2021 | 380 | 253 |
|
| Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018 | Antimicrobial resistance and infection control | | | 2021 | 393 | 189 |
|
| Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study | American journal of transplantation | | | 2021 | 160 | 170 |
|
| Clinical considerations of isavuconazole administration in high-risk hematological patients: a single-center 5-year experience | Mycopathologia | | | 2021 | 251 | 367 |
|
| Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients | Medical mycology | | | 2021 | 371 | 1 |
|
| Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response | BMC infectious diseases | | | 2021 | 166 | 401 |
|
| Differences between infectious disease events in first liver transplant versus retransplantation in the Swiss Transplant Cohort Study | Liver transplantation | | | 2021 | 152 | 0 |
|
| Editorial: Transplant infectious disease landscape in the COVID19-Era | Current opinion in infectious diseases | | | 2021 | 203 | 0 |
|
| The EHA research roadmap: infections in hematology | HemaSphere | | | 2021 | 240 | 274 |
|
| Mapping the human genetic architecture of COVID-19 | Nature | | | 2021 | 10 | 26 |
|
| Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir | Antimicrobial agents and chemotherapy | | | 2021 | 258 | 475 |
|
| Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey | Open forum infectious diseases | | | 2021 | 113 | 165 |
|
| Real-life considerations on antifungal treatment combinations for the management of invasive mold infections after allogeneic cell transplantation | Journal of Fungi | | | 2021 | 197 | 157 |
|
| Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study | The journal of antimicrobial chemotherapy | | | 2021 | 222 | 0 |
|
| Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients | Medical mycology | | | 2021 | 178 | 0 |
|
| Invasive aspergillosis due to Aspergillus section Usti: a multicenter retrospective study | Clinical Infectious Diseases | | | 2020 | 262 | 803 |
|
| Risk factors for candidemia: a prospective matched case-control study | Critical Care | | | 2020 | 392 | 274 |
|
| Response to "Missed diagnosis and misdiagnosis of infectious diseases in hematopoietic cell transplant recipients: an autopsy study" | Blood advances | | | 2020 | 216 | 81 |
|
| Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland | Infection | | | 2020 | 256 | 353 |
|
| First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study | American Journal of Transplantation | | | 2020 | 302 | 171 |
|
| Intracellular Pathogen in the Cerebrospinal Fluid of an Allogeneic Hematopoietic Cell Transplant Recipient With Graft-Versus-Host Disease and Brain Lesions | Clinical infectious diseases | | | 2020 | 281 | 0 |
|
| Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm | Medical Mycology | | | 2020 | 230 | 392 |
|
| Optimal treatment duration of pseudomonas aeruginosa infections in allogeneic hematopoietic cell transplant recipients | Open Forum Infectious Diseases | | | 2020 | 471 | 168 |
|
| First case of Cryptococcus gattii multilobar pneumonia in Switzerland and associated challenges | Swiss Medical Weekly | | | 2020 | 393 | 223 |
|
| Combination treatment with letermovir and ganciclovir for maintenance therapy of multidrug-resistant CMV infection in a liver transplant recipient | Transplantation | | | 2020 | 355 | 1 |
|
| Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5-year analysis within the Swiss Transplant Cohort study | Transplant Infectious Disease | | | 2020 | 414 | 2 |
|
| Prophylaxie antimicrobienne et approches thérapeutiques empiriques et préemptives pour la prévention des infections chez les receveurs de greffe allogénique de cellules hématopoïétiques | | | | 2020 | 603 | 313 |
|
| Infectiologie sur mesure - 1. Immunogénétique des maladies infectieuses : premiers pas | Revue médicale suisse | | | 2019 | 307 | 4 |
|
| National point prevalence survey on healthcare-associated infections in acute care hospitals, Switzerland, 2017 | Euro Surveillance | | | 2019 | 385 | 321 |
|
| Antimicrobial prophylaxis and preemptive approaches for the prevention of infections in the stem cell transplant recipient, with analogies to the hematologic malignancy patient | Infectious disease clinics of North America | | | 2019 | 189 | 671 |
|
| Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study | Transplant Infectious Disease | | | 2018 | 599 | 0 |
|
| Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy | Haematologica | | | 2018 | 261 | 272 |
|
| Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS) | Clinical Microbiology and Infection | | | 2018 | 336 | 242 |
|
| Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients | Transplant Infectious Disease | | | 2018 | 344 | 239 |
|
| Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study | Transplant Infectious Disease | | | 2018 | 479 | 0 |
|
| Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort | Transplant Infectious Disease | | | 2018 | 391 | 1 |
|
| First case of Candida auris in Switzerland: discussion about preventive strategies | Swiss Medical Weekly | | | 2018 | 514 | 347 |
|
